Alimardani V, Farahavar G, Salehi S, Taghizadeh S, Ghiasi MR, Abolmaali SS. Gold nanocages in most cancers prognosis, remedy, and theranostics: a short overview. Entrance Mater Sci. 2021;15:494–511.
Alimardani V, Abolmaali SS, Tamaddon AM, Ashfaq M. Current advances on microneedle arrays-mediated expertise in most cancers prognosis and remedy. Drug Supply Translational Res. 2021;11:788–816.
Alimardani V, Abolmaali SS, Yousefi G, Nowroozzadeh MH, Tamaddon AM. In-situ nanomicelle forming microneedles of poly NIPAAm-b-poly glutamic acid for trans-scleral supply of dexamethasone. J Ind Eng Chem. 2023;119:485–98.
Alimardani V, Rahiminezhad Z, DehghanKhold M, Farahavar G, Jafari M, Abedi M, Moradi L, Niroumand U, Ashfaq M, Abolmaali SS. Nanotechnology-based cell-mediated supply methods for most cancers remedy and prognosis. Drug Supply Translational Res. 2023;13:189–221.
Gani IH, Al-Obaidi Z. MgO NPs catalyzed the synthesis of novel pyridin-3-yl-pyrimidin-2-yl-aminophenyl-amide derivatives and analysis of pharmacokinetic profiles and organic exercise. Entrance Mater. 2023;10:1057677.
Rahiminezhad Z, Tamaddon A, Dehshahri A, Borandeh S, Abolmaali SS, Najafi H, Azarpira N. PLGA-graphene quantum dot nanocomposites focused in opposition to αvβ3 integrin receptor for sorafenib supply in angiogenesis. Biomaterials Adv. 2022;137:212851.
Najmi M, Ayari MA, Sadeghsalehi H, Vaferi B, Khandakar A, Chowdhury ME, Rahman T, Jawhar ZH. Estimating the dissolution of anticancer medicine in supercritical carbon dioxide with a stacked machine studying mannequin. Pharmaceutics. 2022;14(8):1632.
Kadhum WR, Al-Zuhairy SA, Mohamed MB, Abdulrahman AY, Kadhim MM, Alsadoon Z. Teoh. A nanotechnological strategy for enhancing the topical drug supply by newly developed liquid crystal formulations. Int J Drug Deliv Technol. 2022;11:716–20.
Rezaei M, Rahmani E, Khouzani SJ, Rahmannia m, Ghadirzadeh E, Bashghareh P, Chichagi F, Fard SS, Esmaeili S, Tavakoli R, Seighalani HH. Function of synthetic intelligence within the prognosis and therapy of illnesses. Kindle. 2023;3(1):1–160.
Borandeh S, Alimardani V, Abolmaali SS, Seppälä J. Graphene household nanomaterials in ocular purposes: physicochemical properties and toxicity. Chem Res Toxicol. 2021;34:1386–402.
Hoseini-Ghahfarokhi M, Mirkiani S, Mozaffari N, Abdolahi Sadatlu MA, Ghasemi A, Abbaspour S, Akbarian M, Farjadian F, Karimi M. Purposes of Graphene and Graphene Oxide in Good Drug/Gene Supply: is the World nonetheless flat? Int J Nanomed. 2020;15:9469–96.
Alimardani V, Abolmaali SS, Borandeh S. Antifungal and antibacterial properties of graphene-based nanomaterials: a mini-review. J Nanostruct. 2019;9:402–13.
Muazim Ok, Hussain Z. Graphene oxide—A platform in the direction of theranostics. Mater Sci Engineering: C. 2017;76:1274–88.
Hoseini-Ghahfarokhi M, Mirkiani S, Mozaffari N, Abdolahi Sadatlu MA, Ghasemi A, Abbaspour S, Akbarian M, Farjadian F, Karimi M. Purposes of graphene and graphene oxide in good drug/gene supply: is the world nonetheless flat? Int J Nanomed, (2020) 9469–96.
Fedotov А, Prischepa S, Fedotova J, Bayev V, Ronassi AA, Komissarov I, Kovalchuk N, Vorobyova S, Ivashkevich O. Electrical conductivity and magnetoresistance in twisted graphene electrochemically adorned with Co particles. Quantity 117. Physica E: Low-dimensional Methods and Nanostructures; 2020. p. 113790.
Moradi O, Mahdavian L. Simulation and computational research of graphene oxide nano-carriers, absorption, and launch of the anticancer drug of camptothecin. J Mol Mannequin. 2021;27:251.
Bhatt S, Punetha VD, Pathak R, Punetha M. Graphene in nanomedicine: a overview on nano-bio elements and antibacterial exercise. Colloids Surf B, (2023) 113323.
Yang G, Zhang R, Liang C, Zhao H, Yi X, Shen S, Yang Ok, Cheng L, Liu Z. Manganese dioxide coated WS2@ Fe3O4/sSiO2 nanocomposites for pH-responsive MR imaging and oxygen‐elevated synergetic remedy. Small. 2018;14:1702664.
Housman G, Byler S, Heerboth S, Lapinska Ok, Longacre M, Snyder N, Sarkar S. Drug resistance in most cancers: an summary. Cancers. 2014;6:1769–92.
Ashfaq M, Talreja N, Chauhan D, Afreen S, Sultana A, Srituravanich W. Two-dimensional (2D) hybrid nanomaterials for prognosis and therapy of most cancers. J Drug Deliv Sci Technol. 2022;70:103268.
Wang L, Xiong Q, Xiao F, Duan H. 2D nanomaterials based mostly electrochemical biosensors for most cancers prognosis. Biosens Bioelectron. 2017;89:136–51.
Nanda SS, Papaefthymiou GC, Yi DK. Functionalization of graphene oxide and its biomedical purposes. Crit Rev Strong State Mater Sci. 2015;40:291–315.
Zhao W, Ghaznavi A, Gao Y, Wu M, Xu J. Synthesis of a functionalized carbon nanotube graphene composite enabling pH-responsive electrochemical sensing for biomedical purposes. ACS Appl Electron Mater. 2023;5(2):1224–33.
Yang Y, Asiri AM, Tang Z, Du D, Lin Y. Graphene based mostly supplies for biomedical purposes. Mater At this time. 2013;16:365–73.
Chen D, Feng H, Li J. Graphene oxide: preparation, functionalization, and electrochemical purposes. Chem Rev. 2012;112:6027–53.
Wen W, Music Y, Yan X, Zhu C, Du D, Wang S, Asiri AM, Lin Y. Current advances in rising 2D nanomaterials for biosensing and bioimaging purposes. Mater At this time. 2018;21:164–77.
Esteban-Fernández B, de Ávila E, Araque S, Campuzano M, Pedrero B, Dalkiran R, Barderas R, Villalonga E, Kiliç JM, Pingarrón. Twin useful Graphene Spinoff-based Electrochemical platforms for detection of the TP53 gene with single nucleotide polymorphism selectivity in Organic samples. Anal Chem. 2015;87:2290–8.
Shayan S, Osgoei LT, Jouni FJ. Impact of capecitabine and melatonin on HER2+ (SK-BR-3) and HER2-(MCF7) human breast most cancers cell traces. Trop J Pharm Res. 2023;22(7):1387–93.
Kilic T, Erdem A, Erac Y, Seydibeyoglu MO, Okur S, Ozsoz M. Electrochemical Detection of a Most cancers Biomarker Mir-21 in cell lysates utilizing Graphene Modified sensors. Electroanalysis. 2015;27:317–26.
Azimzadeh M, Rahaie M, Nasirizadeh N, Ashtari Ok, Naderi-Manesh H. An electrochemical nanobiosensor for plasma miRNA-155, based mostly on graphene oxide and gold nanorod, for early detection of breast most cancers. Biosens Bioelectron. 2016;77:99–106.
Tran HV, Piro B, Reisberg S, Duc HT, Pham MC. Antibodies Directed to RNA/DNA hybrids: an Electrochemical Immunosensor for MicroRNAs detection utilizing graphene-composite electrodes. Anal Chem. 2013;85:8469–74.
Rusling JF, Kumar CV, Gutkind JS, Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of most cancers. Analyst. 2010;135:2496–511.
Chikkaveeraiah BV, Bhirde AA, Morgan NY, Eden HS, Chen X. Electrochemical immunosensors for detection of Most cancers protein biomarkers. ACS Nano. 2012;6:6546–61.
Feng L, Wu L, Wang J, Ren J, Miyoshi D, Sugimoto N, Qu X. Detection of a prognostic indicator in early-stage most cancers utilizing functionalized graphene‐based mostly peptide sensors. Adv Mater. 2012;24:125–31.
Wei T, Tu W, Zhao B, Lan Y, Bao J, Dai Z. Electrochemical monitoring of an vital biomarker and goal protein: VEGFR2 in cell lysates. Sci Rep. 2014;4:3982.
Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol. 2008;4:278–86.
Chang H, Wang X, Shiu Ok-Ok, Zhu Y, Wang J, Li Q, Chen B, Jiang H. Layer-by-layer meeting of graphene, au and poly(toluidine blue O) movies sensor for analysis of oxidative stress of tumor cells elicited by hydrogen peroxide. Biosens Bioelectron. 2013;41:789–94.
Xiao F, Li Y, Zan X, Liao Ok, Xu R, Duan H. Progress of steel–steel oxide nanostructures on freestanding graphene paper for versatile biosensors. Adv Funct Mater. 2012;22:2487–94.
Nawrot W, Drzozga Ok, Baluta S, Cabaj J, Malecha Ok. A fluorescent biosensors for detection important physique fluids’ brokers. Sensors. 2018;18:2357.
He Y, Lin Y, Tang H, Pang D. A graphene oxide-based fluorescent aptasensor for the turn-on detection of epithelial tumor marker mucin 1. Nanoscale. 2012;4:2054–9.
Tan J, Lai Z, Zhong L, Zhang Z, Zheng R, Su J, Huang Y, Huang P, Music H, Yang N, Zhou S, Zhao Y. A Graphene Oxide-Based mostly Fluorescent Aptasensor for the Flip-on Detection of CCRF-CEM, Nanoscale Analysis Letters, 13 (2018) 66.
Loh KP, Bao Q, Eda G, Chhowalla M. Graphene oxide as a chemically tunable platform for optical purposes. Nat Chem. 2010;2:1015–24.
Lu C-H, Zhu C-L, Li J, Liu J-J, Chen X, Yang H-H. Utilizing graphene to guard DNA from cleavage throughout mobile supply. Chem Commun. 2010;46:3116–8.
Cai B, Wang S, Huang L, Ning Y, Zhang Z, Zhang G-J. Ultrasensitive label-free detection of PNA–DNA hybridization by decreased Graphene Oxide Subject-Impact Transistor Biosensor. ACS Nano. 2014;8:2632–8.
Cai B, Huang L, Zhang H, Solar Z, Zhang Z, Zhang G-J. Gold nanoparticles-decorated graphene field-effect transistor biosensor for femtomolar MicroRNA detection. Biosens Bioelectron. 2015;74:329–34.
Hu SH, Chen YW, Hung WT, Chen IW, Chen SY. Quantum-dot‐tagged decreased graphene oxide nanocomposites for shiny fluorescence bioimaging and photothermal remedy monitored in situ. Adv Mater. 2012;24:1748–54.
Antwi-Boasiako AA, Dunn D, Dasary SS, Jones YK, Barnes SL, Singh AK. Bioconjugated graphene oxide‐based mostly Raman probe for selective identification of SKBR3 breast most cancers cells. J Raman Spectrosc. 2017;48:1056–64.
Dojčilović R, Pajović JD, Božanić DK, Jović N, Pavlović VP, Pavlović VB, Acković LL, Zeković I, Dramićanin M, Kaščaková S, Réfrégiers M, Rašić G, Vlahović B, Djoković V. 2D Mater. 2018;5:045019. DUV fluorescence bioimaging research of the interplay of partially decreased graphene oxide and liver most cancers cells.
Younis MR, He G, Lin J, Huang P. Current advances on Graphene Quantum Dots for Bioimaging Purposes. Entrance Chem, 8 (2020).
McCallion C, Burthem J, Rees-Unwin Ok, Golovanov A, Pluen A. Graphene in therapeutics supply: issues, options and future alternatives. Eur J Pharm Biopharm. 2016;104:235–50.
Yang Ok, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The affect of floor chemistry and measurement of nanoscale graphene oxide on photothermal remedy of most cancers utilizing ultra-low laser energy. Biomaterials. 2012;33:2206–14.
Dasari Shareena TP, McShan D, Dasmahapatra AK, Tchounwou PB. A overview on graphene-based nanomaterials in biomedical purposes and dangers in atmosphere and well being. Nano-micro Lett. 2018;10:1–34.
Wu H, Lu W, Shao J-J, Zhang C, Wu M-B, Li B-H, Yang Q-h. Ph-dependent measurement, floor chemistry and electrochemical properties of graphene oxide. Carbon. 2014;67:795.
Muthoosamy Ok, Abubakar IB, Bai RG, Loh H-S, Manickam S. Exceedingly larger co-loading of Curcumin and Paclitaxel onto Polymer-functionalized decreased Graphene Oxide for extremely potent synergistic Anticancer therapy. Sci Rep. 2016;6:32808.
Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug supply purposes. Acta Biomater. 2013;9:9243–57.
Liu Z, Robinson JT, Solar X, Dai H. PEGylated nanographene oxide for supply of water-insoluble most cancers medicine. J Am Chem Soc. 2008;130:10876–7.
Sahoo NG, Bao H, Pan Y, Pal M, Kakran M, Cheng HKF, Li L, Tan LP. Functionalized carbon nanomaterials as nanocarriers for loading and supply of a poorly water-soluble anticancer drug: a comparative research. Chem Commun. 2011;47:5235–7.
Morimune S, Nishino T, Goto T. Poly(vinyl alcohol)/graphene oxide nanocomposites ready by a easy eco-process. Polym J. 2012;44:1056–63.
Gao J, Bao F, Feng L, Shen Ok, Zhu Q, Wang D, Chen T, Ma R, Yan C. Functionalized graphene oxide modified polysebacic anhydride as drug provider for levofloxacin managed launch. RSC Adv. 2011;1:1737–44.
Pan Y, Bao H, Sahoo NG, Wu T, Li L. Water-soluble poly (N‐isopropylacrylamide)–graphene sheets synthesized through click on chemistry for drug supply. Adv Funct Mater. 2011;21:2754–63.
Zhang L, Lu Z, Zhao Q, Huang J, Shen H, Zhang Z. Enhanced chemotherapy efficacy by sequential supply of siRNA and anticancer medicine utilizing PEI-grafted graphene oxide. Small. 2011;7:460–4.
Chen B, Liu M, Zhang L, Huang J, Yao J, Zhang Z. Polyethylenimine-functionalized graphene oxide as an environment friendly gene supply vector. J Mater Chem. 2011;21:7736–41.
Depan D, Shah J, Misra RDK. Managed launch of drug from folate-decorated and graphene mediated drug supply system: synthesis, loading effectivity, and drug launch response. Mater Sci Engineering: C. 2011;31:1305–12.
Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, Li J, Gan LH. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene supply. Small. 2011;7:1569–78.
Hu H, Yu J, Li Y, Zhao J, Dong H. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug supply. J Biomedical Mater Res Half A. 2012;100:141–8.
Li R, Wang Y, Du J, Wang X, Duan A, Gao R, Liu J, Li B. Graphene oxide loaded with tumor-targeted peptide and anti-cancer medicine for most cancers goal remedy. Sci Rep. 2021;11:1725.
Wei G, Yan M, Dong R, Wang D, Zhou X, Chen J, Hao J. Covalent modification of decreased graphene oxide by way of diazonium chemistry and use as a drug-delivery system, Chemistry (Weinheim an Der Bergstrasse. Germany). 2012;18:14708–16.
Wang X, Han Q, Yu N, Li J, Yang L, Yang R, Wang C. Aptamer–conjugated graphene oxide–gold nanocomposites for focused chemo-photothermal remedy of most cancers cells. J Mater Chem B. 2015;3:4036–42.
Wei Y, Zhou F, Zhang D, Chen Q, Xing D. A graphene oxide based mostly good drug supply system for tumor mitochondria-targeting photodynamic remedy. Nanoscale. 2016;8:3530–8.
Guo W, Chen Z, Feng X, Shen G, Huang H, Liang Y, Zhao B, Li G, Hu Y. Graphene oxide (GO)-based nanosheets with mixed chemo/photothermal/photodynamic remedy to beat gastric most cancers (GC) paclitaxel resistance by lowering mitochondria-derived adenosine-triphosphate (ATP). J Nanobiotechnol. 2021;19:146.
Yang Y-Y, Zhang W, Liu H, Jiang J-J, Wang W-J, Jia Z-Y. Cell-penetrating peptide-modified graphene oxide nanoparticles loaded with rictor siRNA for the therapy of triple-negative breast most cancers. Drug Design, Improvement and Remedy; 2021. pp. 4961–72.
Fan X, Jiao G, Zhao W, Jin P, Li X. Magnetic Fe3O4–graphene composites as focused drug nanocarriers for pH-activated launch. Nanoscale. 2013;5:1143–52.
Deb A, Andrews NG, Raghavan V. Pure polymer functionalized graphene oxide for co-delivery of anticancer medicine: In-vitro and in-vivo. Int J Biol Macromol. 2018;113:515–25.
Deb A, Vimala R. Camptothecin loaded graphene oxide nanoparticle functionalized with polyethylene glycol and folic acid for anticancer drug supply. J Drug Deliv Sci Technol. 2018;43:333–42.
Liu L, Wei Y, Zhai S, Chen Q, Xing D. Dihydroartemisinin and transferrin dual-dressed nano-graphene oxide for a pH-triggered chemotherapy. Biomaterials. 2015;62:35–46.
Matiyani M, Rana A, Pal M, Rana S, Melkani AB, Sahoo NG. Polymer grafted magnetic graphene oxide as a possible nanocarrier for pH-responsive supply of sparingly soluble quercetin in opposition to breast most cancers cells. RSC Adv. 2022;12:2574–88.
Hussien N.A., Işıklan N., Türk M. Pectin-conjugated magnetic graphene oxide nanohybrid as a novel drug provider for paclitaxel supply. Artif Cells Nanomed Biotechnol. 2018;46:264–73.
Rao Z, Ge H, Liu L, Zhu C, Min L, Liu M, Fan L, Li D. Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug supply system. Int J Biol Macromol. 2018;107:1184–92.
Parvaneh S, Pourmadadi M, Abdouss M, Pourmousavi SA, Yazdian F, Rahdar A, Díez-Pascual AM. Carboxymethyl cellulose/starch/decreased graphene oxide composite as a pH-sensitive nanocarrier for curcumin drug supply. Int J Biol Macromol. 2023;241:124566.
Wen H, Dong C, Dong H, Shen A, Xia W, Cai X, Music Y, Li X, Li Y, Shi D. Engineered redox-responsive PEG detachment mechanism in PEGylated nano‐graphene oxide for intracellular drug supply. Small. 2012;8:760–9.
Chen H, Wang Z, Zong S, Wu L, Chen P, Zhu D, Wang C, Xu S, Cui Y. SERS-Fluorescence monitored drug launch of a redox-responsive Nanocarrier based mostly on Graphene Oxide in Tumor cells. ACS Appl Mater Interfaces. 2014;6:17526–33.
Al-Nahain A, Lee SY, In I, Lee KD, Park SY. Triggered pH/redox responsive launch of doxorubicin from ready extremely secure graphene with thiol grafted Pluronic. Int J Pharm. 2013;450:208–17.
Cho Y, Choi Y. Graphene oxide–photosensitizer conjugate as a redox-responsive theranostic agent. Chem Commun. 2012;48:9912–4.
Bardajee GR, Hooshyar Z, Farsi M, Mobini A, Sang G. Synthesis of a novel thermo/pH delicate nanogel based mostly on salep modified graphene oxide for drug launch. Mater Sci Engineering: C. 2017;72:558–65.
Wang C, Mallela J, Garapati US, Ravi S, Chinnasamy V, Girard Y, Howell M, Mohapatra S. A chitosan-modified graphene nanogel for noninvasive managed drug launch. Nanomed Nanotechnol Biol Med. 2013;9:903–11.
Makharza S.A., Cirillo G, Vittorio O, Valli E, Voli F, Farfalla A, Curcio M, Iemma F, Nicoletta F.P., El-Gendy A.A. Magnetic graphene oxide nanocarrier for focused supply of cisplatin: a perspective for glioblastoma therapy. Prescribed drugs. 2019;12:76.
Pramanik N, Ranganathan S, Rao S, Suneet Ok, Jain S, Rangarajan A, Jhunjhunwala S. A composite of hyaluronic acid-modified graphene oxide and iron oxide nanoparticles for focused drug supply and magnetothermal remedy. ACS Omega. 2019;4:9284–93.
Ma X, Tao H, Yang Ok, Feng L, Cheng L, Shi X, Li Y, Guo L, Liu Z. A functionalized graphene oxide-iron oxide nanocomposite for magnetically focused drug supply, photothermal remedy, and magnetic resonance imaging. Nano Res. 2012;5:199–212.
Swain AK, Pradhan L, Bahadur D. Polymer stabilized Fe3O4-Graphene as an amphiphilic drug provider for Thermo-Chemotherapy of Most cancers. ACS Appl Mater Interfaces. 2015;7:8013–22.
Guo L, Shi H, Wu H, Zhang Y, Wang X, Wu D, An L, Yang S. Prostate most cancers focused multifunctionalized graphene oxide for magnetic resonance imaging and drug supply. Carbon. 2016;107:87–99.
Wang C, Ravi S, Garapati US, Das M, Howell M, Mallela J, Alwarappan S, Mohapatra SS, Mohapatra S. Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of medication, genes and MRI distinction brokers. J Mater Chem B. 2013;1:4396–405.
Wang C, Li B, Niu W, Hong S, Saif B, Wang S, Dong C. Shuang, β-Cyclodextrin modified graphene oxide–magnetic nanocomposite for focused supply and pH-sensitive launch of stereoisomeric anti-cancer medicine. RSC Adv. 2015;5:89299–308.
Xie M, Zhang F, Peng H, Zhang Y, Li Y, Xu Y, Xie J. Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for focused drug supply and photothermal remedy. Colloids Surf B. 2019;176:462–70.
Shirvalilou S, Khoei S, Khoee S, Raoufi NJ, Karimi MR, Shakeri-Zadeh A. Improvement of a magnetic nano-graphene oxide provider for improved glioma-targeted drug supply and imaging: in vitro and in vivo evaluations. Chemico-Biol Work together. 2018;295:97–108.
Gupta J, Prakash A, Jaiswal MK, Agarrwal A, Bahadur D. Superparamagnetic iron oxide-reduced graphene oxide nanohybrid-a car for focused drug supply and hyperthermia therapy of most cancers. J Magn Magn Mater. 2018;448:332–8.
Wang Y, Wang H, Liu D, Music S, Wang X, Zhang H. Graphene oxide covalently grafted upconversion nanoparticles for mixed NIR mediated imaging and photothermal/photodynamic most cancers remedy. Biomaterials. 2013;34:7715–24.
Tran TH, Nguyen HT, Pham TT, Choi JY, Choi HG, Yong CS, Kim JO. Improvement of a Graphene Oxide Nanocarrier for Twin-Drug Chemo-Phototherapy to beat Drug Resistance in Most cancers. ACS Appl Mater Interfaces. 2015;7:28647–55.
Shi J, Wang B, Chen Z, Liu W, Pan J, Hou L, Zhang Z. A multi-functional Tumor Theranostic Nanoplatform for MRI guided Photothermal-Chemotherapy. Pharm Res. 2016;33:1472–85.
Music J, Yang X, Jacobson O, Lin L, Huang P, Niu G, Ma Q, Chen X. Sequential drug launch and enhanced Photothermal and Photoacoustic Impact of Hybrid decreased Graphene Oxide-Loaded Ultrasmall Gold Nanorod vesicles for Most cancers Remedy. ACS Nano. 2015;9:9199–209.
Vinothini Ok, Rajendran NK, Rajan M, Ramu A, Marraiki N, Elgorban AM. A magnetic nanoparticle functionalized decreased graphene oxide-based drug provider system for a chemo-photodynamic most cancers remedy. New J Chem. 2020;44:5265–77.
Lu SL, Wang YH, Liu GF, Wang L, Li Y, Guo ZY, Cheng C. Graphene Oxide nanoparticle-loaded Ginsenoside Rg3 improves photodynamic remedy in inhibiting malignant development and stemness of Osteosarcoma. Entrance Mol Biosci. 2021;8:663089.
Karimi M, Eslami M, Sahandi-Zangabad P, Mirab F, Farajisafiloo N, Shafaei Z, Ghosh D, Bozorgomid M, Dashkhaneh F, Hamblin MR. pH‐Delicate stimulus‐responsive nanocarriers for focused supply of therapeutic brokers. Wiley Interdisciplinary Evaluations: Nanomed Nanobiotechnol. 2016;8:696–716.
Kavitha T, Abdi SIH, Park S-Y. pH-sensitive nanocargo based mostly on good polymer functionalized graphene oxide for site-specific drug supply. Phys Chem Chem Phys. 2013;15:5176–85.
Solar X, Liu Z, Welsher Ok, Robinson JT, Goodwin A, Zaric S, Dai H. Nano-graphene oxide for mobile imaging and drug supply. Nano Res. 2008;1:203–12.
Guo Y, Xu H, Li Y, Wu F, Li Y, Bao Y, Yan X, Huang Z, Xu P. Hyaluronic acid and arg-gly-asp peptide modified Graphene oxide with twin receptor-targeting operate for most cancers remedy. J Biomater Appl. 2017;32:54–65.
Wang C, Chen B, Zou M, Cheng G. Cyclic RGD-modified chitosan/graphene oxide polymers for drug supply and mobile imaging. Colloids Surf B. 2014;122:332–40.
Boddu A, Reddy OS, Zhang D, Rao KK, Lai W-F. ROS-generating, pH-responsive and extremely tunable decreased graphene oxide-embedded microbeads exhibiting intrinsic anticancer properties and multi-drug co-delivery capability for mixture most cancers remedy. Drug Supply. 2022;29:2481–90.
Cheng R, Feng F, Meng F, Deng C, Feijen J, Zhong Z. Glutathione-responsive nano-vehicles as a promising platform for focused intracellular drug and gene supply. J Managed Launch. 2011;152:2–12.
Zhao X, Yang L, Li X, Jia X, Liu L, Zeng J, Guo J, Liu P. Functionalized Graphene Oxide nanoparticles for Most cancers Cell-Particular Supply of Antitumor Drug. Bioconjug Chem. 2015;26:128–36.
Ma N, Music A, Li Z, Luan Y. Redox-Delicate Prodrug molecules Meet Graphene Oxide: an environment friendly graphene oxide-based nanovehicle towards Most cancers Remedy. ACS Biomaterials Sci Eng. 2019;5:1384–91.
Kim DJ, Kim J, Lee HL, Lee S, Choi JS, Kim SJ, Jeong YI, Kang DH. Redox-Responsive nanocomposites composed of Graphene Oxide and Chlorin e6 for photodynamic therapy of Cholangiocarcinoma. Bull Korean Chem Soc. 2018;39:1073–82.
Yin T, Liu J, Zhao Z, Zhao Y, Dong L, Yang M, Zhou J, Huo M. Redox delicate hyaluronic acid-decorated graphene oxide for photothermally managed tumor‐cytoplasm‐selective speedy drug supply. Adv Funct Mater. 2017;27:1604620.
Search engine optimization HI, Cheon YA, Chung BG. Graphene and Thermo-responsive polymeric nanocomposites for therapeutic purposes. Biomed Eng Lett. 2016;6:10–5.
Farjadian F, Ghasemi S, Andami Z, Tamami B. Thermo-responsive nanocarrier based mostly on poly (N-isopropylacrylamide) serving as a sensible doxorubicin supply system. Iran Polym J. 2020;29:197–207.
Khanizadeh L, Sarvari R, Massoumi B, Agbolaghi S, Beygi-Khosrowshahi Y. Twin nano-carriers utilizing polylactide-block-poly (n-isopropylacrylamide-random-acrylic acid) polymerized from decreased graphene oxide floor for doxorubicin supply purposes. J Ultrafine Grained Nanostructured Mater. 2020;53:60–70.
Khoee S, Karimi MR. Twin-drug loaded Janus graphene oxide-based thermoresponsive nanoparticles for focused remedy. Polymer. 2018;142:80–98.
Liang J, Chen B, Hu J, Huang Q, Zhang D, Wan J, Hu Z, Wang B. pH and Thermal Twin-Responsive Graphene Oxide nanocomplexes for focused drug supply and Photothermal-Chemo/Photodynamic synergetic remedy. ACS Appl Bio Mater. 2019;2:5859–71.
Huang D, Solar L, Huang L, Chen Y. Nanodrug supply methods modulate tumor vessels to extend the improved permeability and retention impact. J Customized Med. 2021;11(2):124.
Zhang B, Yu Q, Liu Y. Alternating magnetic area managed focused drug supply based mostly on Graphene Oxide-Grafted Nanosupramolecules. Chemistry–A Eur J. 2020;26:13698–703.
Yang X, Wang Y, Huang X, Ma Y, Huang Y, Yang R, Duan H, Chen Y. Multi-functionalized graphene oxide based mostly anticancer drug-carrier with dual-targeting operate and pH-sensitivity. J Mater Chem. 2011;21:3448–54.
Wang Z, Zhou C, Xia J, Through B, Xia Y, Zhang F, Li Y, Xia L. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier. Colloids Surf B. 2013;106:60–5.
Işıklan N, Hussien NA, Türk M. Synthesis and drug supply efficiency of gelatin-decorated magnetic graphene oxide nanoplatform. Colloids Surf a. 2021;616:126256.
Li D, Deng M, Yu Z, Liu W, Zhou G, Li W, Wang X, Yang D-P, Zhang W. Biocompatible and secure GO-Coated Fe3O4 nanocomposite: a sturdy drug supply provider for Simultaneous Tumor MR Imaging and focused remedy. ACS Biomaterials Sci Eng. 2018;4:2143–54.
Chawda N, Basu M, Majumdar D, Poddar R, Mahapatra SK, Banerjee I. Engineering of Gadolinium-decorated Graphene Oxide nanosheets for Multimodal Bioimaging and Drug Supply. ACS Omega. 2019;4:12470–9.
Gonzalez-Rodriguez R, Campbell E, Naumov A. Multifunctional graphene oxide/iron oxide nanoparticles for magnetic focused drug supply twin magnetic resonance/fluorescence imaging and most cancers sensing. PLoS ONE. 2019;14:e0217072.
Music J, Qu J, Swihart MT, Prasad PN. Close to-IR responsive nanostructures for nanobiophotonics: rising impacts on nanomedicine. Nanomed Nanotechnol Biol Med. 2016;12:771–88.
Zhou L, Jiang H, Wei S, Ge X, Zhou J, Shen J. Excessive-efficiency loading of hypocrellin B on graphene oxide for photodynamic remedy. Carbon. 2012;50:5594–604.
Tian B, Wang C, Zhang S, Feng L, Liu Z. Photothermally enhanced photodynamic remedy delivered by nano-graphene oxide. ACS Nano. 2011;5:7000–9.
Kim H, Lee D, Kim J, Kim T-i, Kim WJ. Photothermally triggered cytosolic drug supply through endosome disruption utilizing a Functionalized decreased Graphene Oxide. ACS Nano. 2013;7:6735–46.
Kurapati R, Raichur AM. Close to-infrared light-responsive graphene oxide composite multilayer capsules: a novel route for distant managed drug supply. Chem Commun. 2013;49:734–6.
Du P, Yan J, Lengthy S, Xiong H, Wen N, Cai S, Wang Y, Peng D, Liu Z, Liu Y. Tumor microenvironment and NIR laser dual-responsive launch of berberine 9-O-pyrazole alkyl spinoff loaded in graphene oxide nanosheets for chemo-photothermal synergetic most cancers remedy. J Mater Chem B. 2020;8:4046–55.
Liu W, Zhang X, Zhou L, Shang L, Su Z. Lowered graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for mixed chemo-photothermal remedy. J Colloid Interface Sci. 2019;536:160–70.
Ha W, Zhao X-B, Jiang Ok, Kang Y, Chen J, Li B-J, Shi Y-P. A 3-dimensional graphene oxide supramolecular hydrogel for infrared light-responsive cascade launch of two anticancer medicine. Chem Commun. 2016;52:14384–7.
Wang P, Huang C, Xing Y, Fang W, Ren J, Yu H, Wang G. NIR-light-and pH-responsive graphene oxide hybrid cyclodextrin-based supramolecular hydrogels, Langmuir, 35 (2019) 1021–1031.
Wu J, Li Z, Li Y, Pettitt A, Zhou F. Photothermal results of decreased Graphene Oxide on Pancreatic Most cancers. Technol Most cancers Res Deal with. 2018;17:1533034618768637.
Cheon Y.A., Bae J.H., Chung B.G. Lowered Graphene Oxide Nanosheet for Chemo-Photothermal Remedy. Langmuir. 2016;32:2731–6.
Lim JH, Kim DE, Kim E-J, Ahrberg CD, Chung BG. Useful graphene oxide-based nanosheets for Photothermal Remedy. Macromol Res. 2018;26:557–65.
Dolatkhah M, Hashemzadeh N, Barar J, Adibkia Ok, Aghanejad A, Barzegar-Jalali M, Omidian H, Omidi Y. Stimuli-responsive graphene oxide and methotrexate-loaded magnetic nanoparticles for breast cancer-targeted remedy. Nanomedicine. 2021;16:2155–74.
Park JH, Yoon J-Ok, Kim Y-J, Lee T-J, Jeong G-J, Kim D-I, Bhang SH. Enhancing therapeutic efficacy of photothermal remedy utilizing poloxamer-reduced graphene oxide and mesenchymal stem cells. J Ind Eng Chem. 2019;80:846–53.
Shao L, Zhang R, Lu J, Zhao C, Deng X, Wu Y. Mesoporous silica coated polydopamine functionalized decreased Graphene Oxide for Synergistic focused chemo-photothermal remedy. ACS Appl Mater Interfaces. 2017;9:1226–36.
Jiang W, Mo F, Lin Y, Wang X, Xu L, Fu F. Tumor focusing on twin stimuli responsive controllable launch nanoplatform based mostly on DNA-conjugated decreased graphene oxide for chemo-photothermal synergetic most cancers remedy. J Mater Chem B. 2018;6:4360–7.
Xu X, Wang J, Wang Y, Zhao L, Li Y, Liu C. Formation of graphene oxide-hybridized nanogels for combinative anticancer remedy. Quantity 14. Nanomedicine: Nanotechnology, Biology and Drugs; 2018. pp. 2387–95.
Tang Y, Hu H, Zhang MG, Music J, Nie L, Wang S, Niu G, Huang P, Lu G, Chen X. An aptamer-targeting photoresponsive drug supply system utilizing off–on graphene oxide wrapped mesoporous silica nanoparticles. Nanoscale. 2015;7:6304–10.
Fan H-y, Yu X-h, Wang Ok, Yin Y-j, Tang Y-j, Tang Y-l. -h. Liang, Graphene quantum dots (GQDs)-based nanomaterials for enhancing photodynamic remedy in most cancers therapy. Eur J Med Chem. 2019;182:111620.
Qidwai A, Nabi B, Kotta S, Narang JK, Baboota S, Ali J. Function of nanocarriers in photodynamic remedy. Photodiagn Photodyn Ther. 2020;30:101782.
Sahu A, Choi WI, Lee JH, Tae G. Graphene oxide mediated supply of methylene blue for mixed photodynamic and photothermal remedy. Biomaterials. 2013;34:6239–48.
Gulzar A, Xu J, Yang D, Xu L, He F, Gai S, Yang P. Nano-graphene oxide-UCNP-Ce6 covalently constructed nanocomposites for NIR-mediated bioimaging and PTT/PDT combinatorial remedy. Dalton Trans. 2018;47:3931–9.
Huang P, Xu C, Lin J, Wang C, Wang X, Zhang C, Zhou X, Guo S, Cui D. Folic acid-conjugated graphene oxide loaded with photosensitizers for focusing on photodynamic remedy. Theranostics. 2011;1:240.
Zhou L, Wei S, Ge X, Zhou J, Jiang H, Li F, Shen J. Mixture of chemotherapy and photodynamic remedy utilizing graphene oxide as drug supply system. J Photochem Photobiol B. 2014;135:7–16.
Huang X, Chen J, Wu W, Yang W, Zhong B, Qing X, Shao Z. Supply of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic remedy triggers cell dying in osteosarcoma. Acta Biomater. 2020;109:229–43.
Ding Y-F, Kwong CHT, Li S, Pan Y-T, Wei J, Wang L-H, Mok GSP, Wang R. Supramolecular nanomedicine derived from cucurbit[7]uril-conjugated nano-graphene oxide for multi-modality most cancers remedy. Biomaterials Sci. 2021;9:3804–13.
Duan G, Zhang Y, Luan B, Weber JK, Zhou RW, Yang Z, Zhao L, Xu J, Luo J, Zhou R. Graphene-Induced Pore Formation Cell Membr Sci Rep. 2017;7:42767.
Liao C, Li Y, Tjong SC. Graphene nanomaterials: synthesis, Biocompatibility, and cytotoxicity. Int J Mol Sci, 19 (2018).
Bach D, Wachtel E. Phospholipid/ldl cholesterol mannequin membranes: formation of ldl cholesterol crystallites. Biochim et Biophys Acta (BBA) – Biomembr. 2003;1610:187–97.
Liu JH, Yang ST, Wang H, Chang Y, Cao A, Liu Y. Impact of measurement and dose on the biodistribution of graphene oxide in mice. Nanomed (London England). 2012;7:1801–12.
Mohamed HRH, Welson M, Yaseen AE, El-Ghor AA. Estimation of genomic instability and mutation induction by graphene oxide nanoparticles in mice liver and mind tissues. Environ Sci Pollut Res Int. 2020;27:264–78.
Patlolla AK, Randolph J, Kumari SA, Tchounwou PB. Toxicity analysis of Graphene Oxide in kidneys of Sprague-Dawley rats. Int J Environ Res Public Well being. 2016;13:380.
Wang A, Pu Ok, Dong B, Liu Y, Zhang L, Zhang Z, Duan W, Zhu Y. Function of floor cost and oxidative stress in cytotoxicity and genotoxicity of graphene oxide in the direction of human lung fibroblast cells. J Appl Toxicology: JAT. 2013;33:1156–64.
Pelin M, Fusco L, Martín C, Sosa S, Frontiñán-Rubio J, González-Domínguez JM, Durán-Prado M, Vázquez E, Prato M, Tubaro A. Graphene and graphene oxide induce ROS manufacturing in human HaCaT pores and skin keratinocytes: the position of xanthine oxidase and NADH dehydrogenase. Nanoscale. 2018;10:11820–30.
